Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction


Journal article


Timothy N Audam, Yibing Nong, Alex Tomlin, Andrea Jurkovic, Hong Li, Xiaoping Zhu, Bethany W Long, Yi Wei Zheng, Tyler Weirick, Kenneth R Brittian, Daniel W Riggs, Anna Gumpert, Shizuka Uchida, Yiru Guo, Marcin Wysoczynski, Steven P Jones
Am. J. Physiol. Heart Circ. Physiol., vol. 319, American Physiological Society, 2020 Jul, pp. H109--H122

Cite

Cite

APA
Audam, T. N., Nong, Y., Tomlin, A., Jurkovic, A., Li, H., Zhu, X., … Jones, S. P. (2020). Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction. Am. J. Physiol. Heart Circ. Physiol., 319, H109–H122.

Chicago/Turabian
Audam, Timothy N, Yibing Nong, Alex Tomlin, Andrea Jurkovic, Hong Li, Xiaoping Zhu, Bethany W Long, et al. “Cardiac Mesenchymal Cells from Failing and Nonfailing Hearts Limit Ventricular Dilation When Administered Late after Infarction.” Am. J. Physiol. Heart Circ. Physiol. 319 (July 2020): H109–H122.

MLA
Audam, Timothy N., et al. “Cardiac Mesenchymal Cells from Failing and Nonfailing Hearts Limit Ventricular Dilation When Administered Late after Infarction.” Am. J. Physiol. Heart Circ. Physiol., vol. 319, American Physiological Society, July 2020, pp. H109–H122.


Share